U-M’s ALS Center of Excellence is a Research Site for the Amylyx Pharmaceuticals Drug Preliminary data showing an Amylyx Pharmaceuticals drug as a promising new therapy in slowing the progression of ALS was published in The Wall … [Read more...]
Promising Results from Clinical Drug Trial Covered by The Wall Street Journal
Stephen Goutman, M.D., M.S., Receives ALS Association Grant to Study Environment and Genetics
An ALS Association grant will help Stephen Goutman, M.D., M.S., associate director of the University of Michigan (U-M) ALS Center of Excellence, answer the most common question asked by patients suffering from amyotrophic lateral … [Read more...]
